Overexpression of CDKN2B-AS1 in RCC downregulates miR-141, which increases CCND1/CCND2 expression, stimulates proliferation, EMT, clonogenicity, invasion, migration, inhibits apoptosis in vitro and enhances tumor growth in vivo. Here, CDKN2B is linked to renal cell carcinoma.